TPG offered $6.45 per share, & the board rejected it. If it would offer $6.45 again, the board may accept
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025